Cargando…
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm
Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D receptor (VDR) and via classical nuclear signaling pathways. Here, we demonstrate that the VDR can also function in the absence of its ligand...
Autores principales: | Trivedi, Trupti, Zheng, Yu, Fournier, Pierrick G.J., Murthy, Sreemala, John, Sutha, Schillo, Suzanne, Dunstan, Colin R., Mohammad, Khalid S., Zhou, Hong, Seibel, Markus J., Guise, Theresa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432290/ https://www.ncbi.nlm.nih.gov/pubmed/28460457 http://dx.doi.org/10.18632/oncotarget.15803 |
Ejemplares similares
-
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
por: Wright, Laura E., et al.
Publicado: (2016) -
The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021) -
Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling
por: Zheng, Yu, et al.
Publicado: (2017) -
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017) -
Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)